Inventaire - Sus amigos y comunidades son su mejor biblioteca

Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors

autor

Marta Baro

Azeet Narayan

Abhijit A Patel

Patricia Greninger

publicado en: Cancer Research

fecha de publicación: 2018-07-19

Cites articles 43

Fecha

Título

Autores

2018-01-12

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA.

Nitin Sukumar, Katerina Politi, Scott Gettinger, Roy S. Herbst
2017-01-17

The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer.
2017-05-31

Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas.

W. Mark Saltzman
2017-11-06

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers.

Charles Swanton, Nicholas McGranahan, Nicolai J Birkbak, Kimberly C Banks, Richard Lanman, Maximilian Diehn, Trever G Bivona
2017-11-01

Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.

Lerong Li, James Chih-Hsin Yang, Monique B Nilsson, Huiying Sun, Lixia Diao, Diane Liu, Alissa Poteete, Seung-Oe Lim, Vincent Haddad, Lecia V Sequist, Edward S Kim, J. Jack Lee, Ignacio I Wistuba, Mien-Chie Hung, John V Heymach, Daniel Gomez, Waun Ki Hong, Anil Sood
2017-12-01

A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity.

Yaw Shin Ooi, Karim Majzoub, Jan E Carette
2017-12-01

A Global Interactome Map of the Dengue Virus NS1 Identifies Virus Restriction and Dependency Host Factors.

Ali Amara, Pierre-Olivier Vidalain, Beate M. Kümmerer, Claudia Umaña-Diaz, Athena Labeau, Lucie Bonnet-Madin, Ophelie Dejarnac, Mohamed Lamine Hafirassou, Constance Delaugerre
2016-02-01

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

Gad Getz, Leah J Damon, Giulia Siravegna, Alberto Bardelli, Ruslan I Sadreyev, Lecia V Sequist
2016-05-25

Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors

Michael DiDonato, Kwok Kin Wong
2016-10-03

Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells

Daniel P Flaherty, T.A. Lewis, Jennifer E. Golden
2016-12-01

Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line

Jinjian Lu
2016-12-06

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer

Marina Garassino, Vassiliki Papadimitrakopoulou, Bruno Coudert
2015-03-11

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

John T Poirier, Craig H Mermel, Ryohei Katayama, Paul A VanderLaan, Charles Rudin, Lecia V Sequist, Mari Mino-Kenudson, Darrell R Borger
2015-06

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

Enriqueta Felip, Byoung Chul Cho, Pasi A Jänne, Ana Vivancos
2014-06-09

CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance

Tetsuya Mitsudomi, Yasushi Yatabe, Tony Mok, Giuseppe Giaccone
2014-06-11

Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer
2013-04-15

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers

William Pao, Marc Ladanyi, Mark G Kris, Maria E Arcila, Gregory J Riely, Maureen F Zakowski, Camelia S Sima
2013-04-04

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study
2013-01-01

IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations

Begoña Martin-Castillo, Elisabet Cuyàs, Enrique Barrajón-Catalán, Joaquim Bosch-Barrera, Vicente Micol, Javier A Menendez
2013-10-01

HER2 and lung cancer

Federico Cappuzzo
2013-11-07

The quest to overcome resistance to EGFR-targeted therapies in cancer

Pasi A Jänne
2012-03-28

Systematic identification of genomic markers of drug sensitivity in cancer cells

Michael Stratton, P. Andrew Futreal, Graham R. Bignell, Julio Saez-Rodriguez, Cyril H. Benes
2012-05-10

Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing

Azeet Narayan, Abhijit A Patel, Torunn I Yock
2012-07-01

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors

Mark Merchant, Antoni Ribas
2012-10-22

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

David J. Bearss, Kevin R. Coombes, Ignacio I Wistuba, John V Heymach, Roy S. Herbst, George R Blumenschein, Gordon B. Mills
2011-03-23

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Mari Mino-Kenudson, Scott Gettinger, Lecia V Sequist, Kristin Bergethon, Dora Dias-Santagata, A John Iafrate, Arjola K Cosper, Jeffrey A Engelman
2011-11-01

Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies

Ramon Andrade de Mello, Rui Medeiros, A Araújo
2010-04-22

Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy

Hudson H. Freeze
2010-08-16

TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

Zhan Yao, Lukas Kenner
2008-05-05

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.

Pasi A Jänne, Daniel Haber, Lecia V Sequist
2008-05-01

Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells

Hudson H. Freeze
2007-05-18

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

Federico Cappuzzo, Tetsuya Mitsudomi, Lewis C. Cantley, Pasi A Jänne, Tony Mok

Artículo - wd:Q90349512

Welcome to Inventaire

la biblioteca de sus amigos y comunidades

saber más